Patent classifications
A61K36/756
Medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, preparation method therefor and use method thereof
The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.
Medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, preparation method therefor and use method thereof
The present invention discloses a medicine for treatment or adjuvant treatment of acquired immunodeficiency syndrome, a preparation method thereof and use methods thereof. The medicine comprises: lightyellow sophora root, glabrous greenbrier rhizome, bark of Chinese corktree, raw sessile stemona root, alumen, coptis root, cortex dictamni, chinaberry bark and root-bark, pangolin scales, amber, eucommia bark, tree peony bark, clematis root, common cnidium fruit, Chinese angelica, licorice root, common macrocarpium fruit, barbary wolfberry fruit, medicinal indianmulberry root, cherokee rose fruit, chinaroot greenbier rhizome, akebia fruit, milkvetch root, Japanese climbing fern spore, asiatic pennywort herb, mulberry leaf and frankincense. The present invention not only provides the medicine capable of effectively treating the acquired immunodeficiency syndrome, but also enables the medicine to be capable of being used in conjunction with other medical technical means to easily achieve a more ideal treatment effect.
DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF
Disclosed are dosage forms and kits that support the human body during a stress response. The dosages forms can include at least one sensory disrupter, at least one stress-buster and at least one calming reliever. In embodiments, the dosage form can include at least one nervous system component, at least one immune system component, and at least one endocrine system component. Also disclosed are kits containing the dosage forms and methods of preparation and use of such dosage forms.
DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF
Disclosed are dosage forms and kits that support the human body during a stress response. The dosages forms can include at least one sensory disrupter, at least one stress-buster and at least one calming reliever. In embodiments, the dosage form can include at least one nervous system component, at least one immune system component, and at least one endocrine system component. Also disclosed are kits containing the dosage forms and methods of preparation and use of such dosage forms.
DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF
Disclosed are dosage forms and kits that support the human body during a stress response. The dosages forms can include at least one sensory disrupter, at least one stress-buster and at least one calming reliever. In embodiments, the dosage form can include at least one nervous system component, at least one immune system component, and at least one endocrine system component. Also disclosed are kits containing the dosage forms and methods of preparation and use of such dosage forms.
Time release sleep aid system
Compositions for treating a sleep disorder or modifying or improving the sleep-wake cycle in a subject are disclosed herein. In some examples, the composition can comprise one or more sleep promoting active agents, one or more sleep quality active agents, one or more sleep recovery active agents, and optionally one or more next day active agents. The composition can provide an immediate burst release of the one or more sleep promoting active agents, a delayed burst or delayed sustained release of the one or more sleep quality active agents, a delayed burst or delayed sustained release of the one or more sleep recovery active agents, and a delayed burst or delayed sustained release of the one or more next day active agents. The composition can be provided as a daily oral uni-dosage form. Methods of making and using the compositions are also provided.
Time release sleep aid system
Compositions for treating a sleep disorder or modifying or improving the sleep-wake cycle in a subject are disclosed herein. In some examples, the composition can comprise one or more sleep promoting active agents, one or more sleep quality active agents, one or more sleep recovery active agents, and optionally one or more next day active agents. The composition can provide an immediate burst release of the one or more sleep promoting active agents, a delayed burst or delayed sustained release of the one or more sleep quality active agents, a delayed burst or delayed sustained release of the one or more sleep recovery active agents, and a delayed burst or delayed sustained release of the one or more next day active agents. The composition can be provided as a daily oral uni-dosage form. Methods of making and using the compositions are also provided.
Composition for preventing or treating glioblastoma comprising <i>Platycodon grandiflorum </i>A. De Candolle, <i>Scutellaria baicalensis, Phellodendron amurense </i>Ruprecht or <i>Rubus coreanus </i>
The present invention relates to an extract of at least any one selected from the group consisting of Platycodon grandiflorum, Scutellaria baicalensis, Phellodendron amurense Ruprecht, and Rubus coreanus, or a fraction thereof; and to a use of the same for prevention, improvement, or treatment of glioblastoma multiforme.
Composition for preventing or treating glioblastoma comprising <i>Platycodon grandiflorum </i>A. De Candolle, <i>Scutellaria baicalensis, Phellodendron amurense </i>Ruprecht or <i>Rubus coreanus </i>
The present invention relates to an extract of at least any one selected from the group consisting of Platycodon grandiflorum, Scutellaria baicalensis, Phellodendron amurense Ruprecht, and Rubus coreanus, or a fraction thereof; and to a use of the same for prevention, improvement, or treatment of glioblastoma multiforme.
Composition for preventing or treating glioblastoma comprising <i>Platycodon grandiflorum </i>A. De Candolle, <i>Scutellaria baicalensis, Phellodendron amurense </i>Ruprecht or <i>Rubus coreanus </i>
The present invention relates to an extract of at least any one selected from the group consisting of Platycodon grandiflorum, Scutellaria baicalensis, Phellodendron amurense Ruprecht, and Rubus coreanus, or a fraction thereof; and to a use of the same for prevention, improvement, or treatment of glioblastoma multiforme.